Logo Image
News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsShortsSponsored WebcastStudent VoicesThe Weekly DoseWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsPartnersPulse PointSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
  • Alzheimer Disease
  • Anxiety
  • Asthma
  • Atopic Dermatitis
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • C. difficile
  • COPD
  • COVID-19
  • Cardiovascular Health
  • Cervical Cancer
  • Cholangiocarcinoma
  • Cholesterol
  • Chronic Kidney Disease
  • Chronic Lymphocytic Leukemia
  • Classical Hematology
  • Colorectal Cancer
  • Continuous Glucose Monitoring
  • Cough and Cold
  • Depression
  • Dermatology
  • Diabetes
  • Digestive Health
  • Dry Eye Disease
  • Endometrial Cancer
  • Epilepsy
  • Eye Care
  • Flu
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
  • Gout
  • HER2 Breast Cancer
  • HIV
  • Heart Failure
  • Hematology
  • Hepatitis/MASH
  • Immunization
  • Immuno-oncology
  • Immunoglobulins
  • Infectious Disease
  • Lung Cancer
  • Lymphoma
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myelofibrosis
  • Neurology
  • Neutropenia
  • Osteoporosis
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Pneumococcal
  • PrEP
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Respiratory Syncytial Virus
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

a

Advertisement

Articles by a

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

ByBrian C. Sauer, PhD,Chia-Chen Teng, MS,Tao He, MS,Jianwei Leng, MS,Chao-Chin Lu, PhD,Jeffrey R. Curtis, MD, MS, MPH,Derek H. Tang, PhD, BSPharm,Neel Shah, PhD, BPharm,David J. Harrison, PhD,a
January 6th 2016

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.

Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

BySophia Pak, PharmD,Mark Bounthavong, PharmD,Melissa L. Christopher, PharmD,Margaret A. Mendes, PharmD,Emerald B. Foster, PharmD,Daniel T. Boggie, PharmD,Jonathan Lacro, PharmD, BCPS, BCPP,a
February 1st 2011

Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.

Advertisement

Latest Updated Articles

  • Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release
    Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

    February 1st 2011

  • Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis
    Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

    January 6th 2016



Advertisement
Advertisement

Trending on Pharmacy Times

1

FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease

2

FDA Clears First Single-Inhaler Triple Therapy for Asthma

3

Metformin Cuts Long COVID Risk by 50%, New Trial Confirms

4

FDA Clears the Way for First Generic Single-Dose Flu Treatment Ahead of 2026 Season

5

Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us